Boryung (A003850) Stock Overview
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
A003850 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Boryung Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,180.00 |
| 52 Week High | ₩11,100.00 |
| 52 Week Low | ₩7,680.00 |
| Beta | 0.61 |
| 1 Month Change | -4.10% |
| 3 Month Change | -1.56% |
| 1 Year Change | -19.01% |
| 3 Year Change | -22.10% |
| 5 Year Change | -47.60% |
| Change since IPO | 1,253.11% |
Recent News & Updates
Recent updates
Additional Considerations Required While Assessing Boryung's (KRX:003850) Strong Earnings
Mar 21
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt
Sep 20Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Shareholder Returns
| A003850 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -6.6% | -1.9% | -3.9% |
| 1Y | -19.0% | 29.1% | 51.2% |
Return vs Industry: A003850 underperformed the KR Pharmaceuticals industry which returned 29.1% over the past year.
Return vs Market: A003850 underperformed the KR Market which returned 51.2% over the past year.
Price Volatility
| A003850 volatility | |
|---|---|
| A003850 Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.0% |
| 10% least volatile stocks in KR Market | 2.5% |
Stable Share Price: A003850 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003850's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 1,533 | Jay Kim | www.boryung.co.kr |
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd.
Boryung Corporation Fundamentals Summary
| A003850 fundamental statistics | |
|---|---|
| Market cap | ₩691.05b |
| Earnings (TTM) | ₩31.80b |
| Revenue (TTM) | ₩1.02t |
Is A003850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003850 income statement (TTM) | |
|---|---|
| Revenue | ₩1.02t |
| Cost of Revenue | ₩656.20b |
| Gross Profit | ₩363.81b |
| Other Expenses | ₩332.01b |
| Earnings | ₩31.80b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 376.43 |
| Gross Margin | 35.67% |
| Net Profit Margin | 3.12% |
| Debt/Equity Ratio | 41.7% |
How did A003850 perform over the long term?
See historical performance and comparisonDividends
Does A003850 pay a reliable dividends?
See A003850 dividend history and benchmarks| Boryung dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Apr 30 2026 |
| Days until Ex dividend | 34 days |
| Days until Dividend pay date | 156 days |
Does A003850 pay a reliable dividends?
See A003850 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/24 22:36 |
| End of Day Share Price | 2025/11/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Boryung Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Myung Sun Lee | DB Financial Investment Co. Ltd. |
| Hyung Soo Kim | Kyobo Securities Co., Ltd |
| Seung-woo Seo | Mirae Asset Securities Co., Ltd. |